Ellipses Pharma Limited
United Arab Emirates · Biotechnology, Health Care, Medical
Ellipses Pharma Limited is a global drug development company focused on accelerating the development of cancer treatments through an innovative drug development model. The company aims to find outstanding potential cancer treatments and develop them swiftly, supported by a strong investor base. Ellipses specializes in next generation selective RET inhibitors for treating RET-altered tumors, partic
Key facts
- Headquarters
- United Arab Emirates
- Employees
- 30
- Industries
- Biotechnology, Health Care, Medical
- Status
- Private
- Website
- ellipses.life
- Company page
Recent activity at Ellipses Pharma Limited
Leadership
- Rajan Jethwa, Chief Executive Officer
- Suzanne Wood, Senior Hr Professional
- Eden Demmisse, Chartered Certified Accountant
- Pritesh Rao Undale, Managing Director
- Graeme Horne, Employee
- Luke Slatford, Head of Digital, Data and Technology
- Arturo Maldonado, Clinical Development Operations
- Tobias Arkenau, CMO and Global Head of Drug Development
- Sital Patel, Strong Background In Oncology
- Ascanio Digiacomo, Life Sciences Professional
- David Cook, Employee At Ellipses Pharma
Verified email and direct lines for Ellipses Pharma Limited’s decision-makers are on Fundz. See plans
Ellipses Pharma Limited in the news
- Pivotal Trial Data for EP0031 (A400), a Next-Generation Selective RET Inhibitor (SRI), in RET Positive Advanced NSCLC, to be Presented at ASCO 2026 - Business Wire (May 22, 2026)
- Ellipses In-Licenses First-in-Class B7H3 Antibody Drug Conjugate From China - Business Wire (Jan 22, 2026)
- A400/EP0031 NDA Accepted for Review in China for RET Fusion–Positive NSCLC - OncLive (Sep 25, 2025)
- Ellipses Announces Growth In Oncology Portfolio - PR Newswire UK (Sep 16, 2021)
- Ellipses In-Licences First in Class Novel Immuno-Oncology Agent With Potential as a Next Generation Checkpoint Inhibitor - Business Wire (Feb 11, 2025)
- Ellipses Launches Pioneering Clinical Trial Programme in Middle East - Business Wire (Dec 23, 2024)
Companies similar to Ellipses Pharma Limited
- NuCana · Biotechnology, Health Care, Medical, Pharmaceutical, Therapeutics
- NRx Pharmaceuticals · Biotechnology, Health Care, Medical, Pharmaceutical, Therapeutics
- Citius Oncology · Biotechnology, Health Care, Medical, Pharmaceutical, Therapeutics
- Specialised Therapeutics · Biotechnology, Health Care, Medical, Pharmaceutical, Therapeutics
- Amplio Pharma · Biotechnology, Health Care, Medical, Pharmaceutical, Therapeutics
About Ellipses Pharma Limited: questions and answers
What does Ellipses Pharma Limited do?
Ellipses Pharma Limited is a global drug development company focused on accelerating the development of cancer treatments through an innovative drug development model. The company aims to find outstanding potential cancer treatments and develop them swiftly, supported by a strong investor base. Ellipses specializes in next generation selective RET inhibitors for treating RET-altered tumors, partic
Where is Ellipses Pharma Limited headquartered?
Ellipses Pharma Limited is headquartered in United Arab Emirates.
How many employees does Ellipses Pharma Limited have?
Ellipses Pharma Limited has about 30 employees.
Who leads Ellipses Pharma Limited?
Rajan Jethwa is a Chief Executive Officer at Ellipses Pharma Limited.
What is the latest news on Ellipses Pharma Limited?
On Feb 11, 2025, Ellipses In-Licences 'GENA-104' for Developing Next-Generation Immuno-Oncology Drug
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy